Supplemental material
Journal of Medical Economics
Volume 25, 2022 - Issue 1
Open access
2,333
Views
4
CrossRef citations to date
0
Altmetric
Transplants
US payer budget impact of a microarray assay with machine learning to evaluate kidney transplant rejection in for-cause biopsies
Lauren Fusfelda Boston Healthcare Associates, Inc. (now a Veranex company), Boston, MA, USACorrespondence[email protected]
https://orcid.org/0000-0003-1650-2876
Sreeranjani Menona Boston Healthcare Associates, Inc. (now a Veranex company), Boston, MA, USA
, Gaurav Guptab Division of Nephrology, Department of Medicine, Virginia Commonwealth University, Richmond, VA, USA
, Christopher Lawrencec Thermo Fisher Scientific, West Hills, CA, USA
, Salwa F. Masuda Boston Healthcare Associates, Inc. (now a Veranex company), Boston, MA, USA
https://orcid.org/0000-0003-2931-7418
Thomas F. Gossa Boston Healthcare Associates, Inc. (now a Veranex company), Boston, MA, USA
Pages 515-523
|
Received 08 Feb 2022, Accepted 24 Mar 2022, Published online: 09 Apr 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.